Search Results 531-540 of 12522 for alp

1. A Study to Investigate Long-term Safety and Tolerability of Tolebrutinib in Participants With Multiple Sclerosis. - Mayo Clinic

   ... alkaline phosphatase more than 2 × ULN (unless caused by non-liver-related disorder or explained by a stable chronic liver disorder) OR total bilirubin more ...

2. A Study of AO-176 as Monotherapy Combinated with Bortezomib and Dexamethasone in Adults with Relapsed or Refractory Multiple Myeloma - Mayo Clinic

   ... alkaline phosphatase in previous 12 months. AST/SGOT and ALT/SGPT ≤ 2.5 x ULN or ≤ 5 x ULN if liver metastases. Transfusion and/or erythropoietin not ...

3. Atezolizumab in Treating Patients With Recurrent BCG-Unresponsive Non-muscle Invasive Bladder Cancer - Mayo Clinic

   Alkaline phosphatase =< 2 x IULN; Serum creatinine =< 1.5 ULN OR measured or calculated creatinine clearance >= 30 mL/min; Patients must have Zubrod ...

4. Interrater Reliability of the Modified Prone Instability Test in Patients with Mechanical Low Back Pain - Mayo Clinic

   Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

5. Teriparatide for Postsurgical Hypoparathyroidism - Mayo Clinic

   Unexplained elevations of alkaline phosphatase. Participating Mayo Clinic locations. Study statuses change often. Please contact the study team for the most ...

6. A Study of APG-2575 Alone or in Combination with Other Therapeutic Agents to Treat Relapsed and/or Refractory Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL) - Mayo Clinic

   Alkaline phosphatase < 3 × ULN. 7. Females of childbearing potential (i.e., not postmenopausal for at least 2 years or surgically sterile) must have ...

7. A Study of the Safety and Effectiveness of HBI-8000 with Nivolumab to Treat Melanoma, Renal Cell Carcinoma and Non-Small Cell Lung Cancer - Mayo Clinic

   ... alkaline phosphatase ≤ 2.5 x ULN unless bone metastases present, bilirubin ≤ 1.5 x ULN (unless known Gilbert's disease where it must be ≤ 3 x ULN) and ...

8. Study of Oraxol and Pembrolizumab in Subjects with Advanced Solid Tumors - Mayo Clinic

   - Alkaline phosphatase ≤ 3 x ULN or ≤ 5 x ULN if bone or liver metastasis is present - Serum creatinine ≤ 2 x ULN, or 24-hr urine creatinine clearance ...

9. A Study to Evaluate Gemcitabine Hydrochloride and Cisplatin With or Without Nab-Paclitaxel in Treating Patients With Newly Diagnosed Advanced Biliary Tract Cancers - Mayo Clinic

   Patients must have sodium, potassium, bicarbonate, chloride, blood urea nitrogen (BUN), calcium, total protein, magnesium, and alkaline phosphatase obtained ...

10. A Study to Evaluate Parsaclisib (INCB050465), Rituximab, Cyclophosphamide, Doxorubicin, Vincristine And Prednisone (Par-CHOP) Immunochemotherapy for Patients with Newly Diagnosed High Risk Diffuse Large B-Cell Lymphoma - Mayo Clinic

    Aspartate transaminase (AST) 3 ULN (≤ 5 ULN for patients with direct liver involvement by lymphoma);; Alkaline phosphatase ≤ 3 ULN, unless evidence of the ...